Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

Stellmann, Jan‐Patrick; Krumbholz, Markus; Friede, Tim; Gahlen, Anna; Borisow, Nadja; Fischer, Katrin; Hellwig, Kerstin; Pache, Florence; Ruprecht, Klemens; Havla, Joachim; Kümpfel, Tania; Aktaş, Orhan; Hartung, Hans‐Peter; Ringelstein, Marius; Geis, Christian; Kleinschnitz, Christoph; Berthele, Achim; Hemmer, Bernhard; Angstwurm, Klemens; Lea Young, Kim; Schuster, Simon; Stangel, Martin; Lauda, Florian; Tumani, Hayrettin; Mayer, Christoph; Zeltner, Lena; Ziemann, Ulf; A. Linker, Ralf; Schwab, Matthias; Marziniak, Martin; Then Bergh, Florian; Hofstadt‐van Oy, Ulrich; Neuhaus, Oliver; K. Zettl, Uwe; Faiss, Jürgen; Wildemann, Brigitte; Paul, Friedemann; Jarius, Sven; Trebst, Corinna; Kleiter, Ingo

doi:10.1136/jnnp-2017-315603

Public

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response

Published in Journal of Neurology Neurosurgery & Psychiatry • Jun 1, 2017

Authors:

Jan‐Patrick Stellmann

Markus Krumbholz

Tim Friede

Abstract

OBJECTIVE: To analyse predictors for relapses and number of attacks under different immunotherapies in patients with neuromyelitis optica spectrum disorder (NMOSD). DESIGN: This is a retrospective cohort study conducted in neurology departments at 21 regional and university hospitals in Germany. Eli...

Subject

Medicine

Neuromyelitis optica

Glatiramer acetate

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!